Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca Deploys Ingenuity Software

NEW YORK (GenomeWeb News) – Ingenuity Systems today said that AstraZeneca has signed a multi-year deal to use the firm's Ingenuity Pathways Analysis software in its research and target discovery programs.

"IPA can support a wide range of research objectives across our target and biomarker discovery programs — such as providing insight into target efficacy, drugability and, increasingly, toxicity," said Ian Dix, principal informatics scientist for AstraZeneca. "The richness and contextual nature of the content is important for us because it provides a detailed view of the molecular basis of disease, critical in the drug discovery decision-making process."

Terms of the agreement were not disclosed.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.